While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.
The K. Lisa Yang Integrative Computational Neuroscience (ICoN) Center will use mathematical tools to transform data into a deep understanding of the brain.
The physicist, neuroscientist, and PhD candidate creates augmentative technology for children with neurodevelopmental differences.
Study suggests a common mechanism underlies some behavioral traits seen in autism and schizophrenia.
Graybiel lab identifies genes linked to abnormal repetitive behaviors often seen in models of addiction and schizophrenia.
The brain uses different frequency rhythms and cortical layers to suppress expected stimulation and increase activity for what’s novel.
The startup Ultranauts offers software and data quality engineering services with a team made up mostly of people on the autism spectrum.
Collaborative research center funded by Lisa Yang and Hock Tan ’75 blends engineering and neuroscience to advance molecular tools for treating brain disorders.
New analysis could help uncover potential drug targets for attention deficits and sensory hypersensitivity.
Among study’s many surprises may be a new way to address Fragile X syndrome — by finding a “protein X.”
Drug compound, tested in mice, could be effective in treating the leading heritable cause of intellectual disability and autism.
Picower Institute researchers are embarking on experiments to learn the mechanisms by which coronavirus might affect mental health.
A new study may explain why people with autism are often highly sensitive to light and noise.
An immune molecule sometimes produced during infection can influence the social behavior of mice.
Findings in mice suggest targeting certain brain circuits could offer new ways to treat some neurological disorders.